Biofrontera(BFRI) - 2025 Q2 - Quarterly Results

Exhibit 99.1 Biofrontera Inc. Reports Second Quarter 2025 Financial Results and Provides a Business Update Woburn, MA, Aug. 13, 2025 (GLOBE NEWSWIRE) — Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy in dermatology, today reported financial results for the three and six months ended June 30, 2025 and provided a business update. Highlights from the first six months of 2025 included the following: Hermann ...